Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nishikawa

Showing results (41-50 of 1,052) with videos related to

Pageof 106
Sort By:
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|January 1, 1993
[Molecular mechanism of trans-kingdom conjugation between Escherichia coli and yeasts]K Yoshida, M Nishikawa
Nihon Naibunpi Gakkai Zasshi|March 20, 1988
[Clinical studies on abnormal thyroid stimulators in patients with Graves' disease. II. Clinical significance of measuring TSAb and TBII in patients with euthyroid Graves' disease and patients with hyperthyroid Graves' disease during antithyroid drug treatment]C Uno, M Nishikawa
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|December 1, 1980
Platelet aggregation and protein phosphorylationH Hidaka, M Nishikawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 1, 1978
[Normal pressure hydrocephalus]H Handa, M Nishikawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 1, 1993
[Behçet's disease]T Sakane, M Nishikawa
Neuroradiology|May 31, 1976
Intracisternal dimer X: toxicity and prophylaxisM Nishikawa, Y Yonekawa
Human Gene Therapy|June 2, 2001
Nonviral vectors in the new millennium: delivery barriers in gene transferM Nishikawa, L Huang
Molecular Pharmacology|July 1, 1981
Conformational analysis of beta 2-adrenoceptor-stimulating agentsM Motohashi, M Nishikawa
Rinsho Byori. the Japanese Journal of Clinical Pathology|April 1, 1985
[Calmodulin]M Nishikawa, H Hidaka
No Shinkei Geka. Neurological Surgery|June 1, 1976
[Dimer-X in the intracranial subarachnoid space--its toxicity (author's transl)]M Nishikawa, Y Yonekawa
Pageof 106

Showing results (41-50 of 1,052) with videos related to

Sort By:
Pageof 106
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|January 1, 1993
[Molecular mechanism of trans-kingdom conjugation between Escherichia coli and yeasts]K Yoshida, M Nishikawa
Nihon Naibunpi Gakkai Zasshi|March 20, 1988
[Clinical studies on abnormal thyroid stimulators in patients with Graves' disease. II. Clinical significance of measuring TSAb and TBII in patients with euthyroid Graves' disease and patients with hyperthyroid Graves' disease during antithyroid drug treatment]C Uno, M Nishikawa
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|December 1, 1980
Platelet aggregation and protein phosphorylationH Hidaka, M Nishikawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 1, 1978
[Normal pressure hydrocephalus]H Handa, M Nishikawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 1, 1993
[Behçet's disease]T Sakane, M Nishikawa
Neuroradiology|May 31, 1976
Intracisternal dimer X: toxicity and prophylaxisM Nishikawa, Y Yonekawa
Human Gene Therapy|June 2, 2001
Nonviral vectors in the new millennium: delivery barriers in gene transferM Nishikawa, L Huang
Molecular Pharmacology|July 1, 1981
Conformational analysis of beta 2-adrenoceptor-stimulating agentsM Motohashi, M Nishikawa
Rinsho Byori. the Japanese Journal of Clinical Pathology|April 1, 1985
[Calmodulin]M Nishikawa, H Hidaka
No Shinkei Geka. Neurological Surgery|June 1, 1976
[Dimer-X in the intracranial subarachnoid space--its toxicity (author's transl)]M Nishikawa, Y Yonekawa
Pageof 106